⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9324253 | 0.85 | — | — | |
| SCHEMBL864016 | 0.81 | — | — | |
| SCHEMBL25497611 | 0.79 | — | — | |
| SCHEMBL5116662 | 0.79 | — | — | |
| SCHEMBL5116658 | 0.79 | — | — | |
| SCHEMBL23964332 | 0.75 | OR51E2 (0.56) | — | |
| SCHEMBL2920862 | 0.72 | — | — | |
| SCHEMBL13058104 | 0.70 | GAA (0.48) | — | |
| SCHEMBL26886694 | 0.70 | OR51E2 (0.50) | — | |
| SCHEMBL586833 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130045962-A1 | PEPTIDE DEFORMYLASE INHIBITORS | GLAXOSMITHKLINE LLC | 2013-02-21 | — | — | US | claimed |
| US-20220219155-A1 | Compositions And Methods For Visible-Light-Controlled Ruthenium-Catalyzed Olefin Metathesis | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2022-07-14 | — | — | US | disclosed |
| CN-111592492-A | Method for improving quality of caprolactam product subjected to liquid phase Beckmann rearrangement | 中国石油化工股份有限公司 | 2020-08-28 | — | — | CN | disclosed |
| US-20140323476-A1 | PEPTIDE DEFORMYLASE INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED (GB) | 2014-10-30 | — | — | US | disclosed |
| US-20130045962-A1 | PEPTIDE DEFORMYLASE INHIBITORS | GLAXOSMITHKLINE LLC | 2013-02-21 | — | — | US | disclosed |
| WO-2013010676-A2 | SUPPORTED IONIC LIQUID PHASE CATALYST | ECOLE NATIONALE SUPERIEURE DE CHIMIE DE RENNES (FR) | 2013-01-24 | — | — | WO | disclosed |
| US-7893056-B2 | Peptide deformylase inhibitors | GLAXOSMITHKLINE LLC (US) | 2011-02-22 | — | — | US | disclosed |
| EP-1648865-B1 | PROCESS FOR PURIFYING CAPROLACTAM | DSM IP ASSETS BV (NL) | 2010-04-21 | — | — | EP | disclosed |
| US-20090306066-A1 | PEPTIDE DEFORMYLASE INHIBITORS | GLAXOSMITHKLINE LLC | 2009-12-10 | — | — | US | disclosed |
| US-20070060750-A1 | Process for purifying caprolactam | DSM IP ASSETS B.V. (NL) | 2007-03-15 | — | — | US | disclosed |
| US-7001899-B2 | Interleukin converting enzyme inhibitors | THE PROCTER & GAMBLE COMPANY (US) | 2006-02-21 | — | — | US | disclosed |
| US-20040009966-A1 | 7-member ring N-heterocycles that have a cysteine trap substitution; treating osteoarthritis | THE PROCTER & GAMBLE COMPANY | 2004-01-15 | — | — | US | disclosed |
| US-5326850-A | Radiation crosslinking, high heat deflection temperature | BASF AKTIENGESELLSCHAFT (DE) | 1994-07-05 | — | — | US | disclosed |
| US-5266656-A | Blends of polyamides and polyamides with olefin bonds | BASF AKTIENGESELLSCHAFT (DE) | 1993-11-30 | — | — | US | disclosed |